Breast cancer: A model for primary and secondary metastasization and clinical consequences;Modell zur primärem und sekundären metastasierung beim mammakarzinom und dessen klinische bedeutung

Strahlentherapie und Onkologie

Volumn 177, Issue 1, 2001, Pages 10-24

  Hölzel, Dieter ^a   Engel, Jutta ^b   Schmidt, Michael ^c   Sauer, Hansjörg ^d  

^a Institut für Med Informationsverarbeitung Biometrie und Epidemiologie   (Germany)

^b Feldstudie Mammakarzinom des Tumorzentrums München   (Germany)

^c Tumorregister   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Breast cancer; Locoregional recurrencies; Primary and secondary metastases; Prognostic factors; Survival

Indexed keywords

ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; ADJUVANT THERAPY; AGED; BIOLOGICAL MODEL; BREAST TUMOR; COHORT ANALYSIS; GERMANY; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REGISTER; TIME; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; REGISTRIES; SURVIVAL RATE; TIME FACTORS;

EID: 0034746748     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002353     Document Type: Article

References (90)

1. Prediction of outcome after first recurrence of breast cancer
2. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination
3. The impact of tumor size and histology on local control after breast-conserving therapy
4. Prognostic factors in recurrent breast cancer: Relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading
5. Effect of delay in radiation in the combined modality treatment of breast cancer
6. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update
7. Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: A 10-year follow-up
8. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy
9. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery
10. Intensive diagnostic follow-up after treatment of primary breast cancer
11. Proposal for a new model of breast cancer metastatic development
12. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy
13. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
14. Tamoxifen for early breast cancer: An overview of the randomised trials
15. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
16. Population-based patient care study for breast cancer
17. Radiotherapy and chemotherapy in high risk breast cancer
18. Significance of ipsilateral breast tumour recurrence after lumpectomy
19. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors
20. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
21. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from national surgical adjuvant breast and bowel project B-18
22. Long-term follow-up of axillary node-postitive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence
23. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy
24. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up
25. Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment
26. Comparative analyses of bone marrow micrometastases in breast and gastric cancer
27. Editorial comment on "The link between local recurrence and distant metastasis in human breast cancer"
28. Meeting highlights: International consensus panel on the treatment of primary breast cancer
29. Prognosis following local recurrence in the conservatively treated breast cancer patient
30. Survival following locoregional recurrence of breast cancer: Univariate and multivariate analysis
31. The growth law of primary breast cancer as inferred from mammography screening trials data
32. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence
33. The significance of local control in the primary treatment of breast cancer
34. The appropriate breast cancer paradigm
35. Stopping metastases at their source
36. Survival after first recurrence in breast cancer
37. Steroid-hormone receptors and survival after first relapse in breast cancer
38. Breast cancer: A systemic or local disease?
39. Radiation therapy and patient age in the survival from early-stage breast cancer
40. Oestrogen receptor status of primary carcinomas and their metastases. Relation to pattern of spread and survival after recurrence
41. Dormancy of mammary carcinoma after mastectomy
42. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence
43. The link between local recurrence and distant metastases in human breast cancer
44. Tamoxifen and breast conservation
45. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis
46. Prognostic factors associated with survival after breast cancer recurrence
47. The importance of locoregional control in the treatment of breast cancer and its impact on survival
48. Micrometastases and survival in stage II colorectal cancer
49. Local recurrence after breast-conserving surgery for breast cancer
50. Outcome of primary-breast-cancer patients with micrometastases: A long-term follow-up study
51. Benefits of postmastectomy radiotherapy
52. The national cancer data base report on breast cancer
53. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
54. Postoperative radiotherapy in high-risk postmenopausal breast-cancer given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomised trial
55. Disseminierte tumorzellen: Diagnostik, prognostische relevanz, phänotypisierung und therapeutische strategien
56. Age-dependent growth rate of primary breast cancer
57. Defining the role of post-mastectomy radiotherapy: The new evidence
58. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
59. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: Sequencing, timing, and outcome
60. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma
61. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer
62. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer
63. Influence of delay on survival in patients with breast cancer: A systematic review
64. Monoclonal antibody therapy for resected dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
65. Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials
66. Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long-term follow-up of a randomized clinical trial
67. Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis
68. Local recurrences after breast-conserving treatment: An open problem
69. Annual hazard rates of recurrence for breast cancer after primary therapy
70. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy
71. Lead time in breast cancer detection and implications for periodicity of screening
72. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer
73. Tumor development, histology and grade of breast cancers: Prognosis and progression
74. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer
75. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast
76. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events
77. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast
78. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy
79. Survival after first recurrence of breast cancer. The Miami experience
80. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer
81. Influence of psychological response on survival in breast cancer: A population-based cohort study
82. Locoregional recurrence of breast cancer following mastectomy: Always a fatal event? Results of univariate and multivariate analysis
83. Radiotherapy and chemotherapy in high risk breast cancer
84. Is the three year breast screening intervall too long? Occurrence of interval cancers in NHS breast screening programme's north western region
85. Benefits of post-mastectomy radiotherapy
86. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
87. Radiotherapy for early breast cancer: Was a comprehensive overview of trials needed?
88. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial